Annual Current Liabilities
$68.21 M
+$43.13 M+172.00%
December 31, 2023
Summary
- As of February 8, 2025, RNAC annual total current liabilities is $68.21 million, with the most recent change of +$43.13 million (+172.00%) on December 31, 2023.
- During the last 3 years, RNAC annual current liabilities has fallen by -$13.34 million (-16.36%).
- RNAC annual current liabilities is now -16.36% below its all-time high of $81.55 million, reached on December 1, 2020.
Performance
RNAC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$21.41 M
-$4.71 M-18.04%
September 1, 2024
Summary
- As of February 8, 2025, RNAC quarterly total current liabilities is $21.41 million, with the most recent change of -$4.71 million (-18.04%) on September 1, 2024.
- Over the past year, RNAC quarterly current liabilities has dropped by -$15.25 million (-41.60%).
- RNAC quarterly current liabilities is now -77.61% below its all-time high of $95.62 million, reached on September 1, 2021.
Performance
RNAC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RNAC Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +172.0% | -41.6% |
| 3 y3 years | -16.4% | -14.6% |
| 5 y5 years | +94.1% | -14.6% |
RNAC Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.6% | +172.0% | -70.4% | +7.3% |
| 5 y | 5-year | -16.4% | +172.0% | -77.6% | +7.3% |
| alltime | all time | -16.4% | +835.6% | -77.6% | +238.8% |
Cartesian Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.41 M(-18.0%) |
| Jun 2024 | - | $26.11 M(-28.8%) |
| Mar 2024 | - | $36.65 M(-46.3%) |
| Dec 2023 | $68.21 M(+172.0%) | $68.21 M(+242.1%) |
| Sep 2023 | - | $19.94 M(-32.1%) |
| Jun 2023 | - | $29.37 M(+10.7%) |
| Mar 2023 | - | $26.53 M(+5.8%) |
| Dec 2022 | $25.08 M(-65.3%) | - |
| Dec 2022 | - | $25.08 M(+5.7%) |
| Sep 2022 | - | $23.73 M(-29.7%) |
| Jun 2022 | - | $33.76 M(-14.0%) |
| Mar 2022 | - | $39.25 M(-45.7%) |
| Dec 2021 | $72.25 M(-11.4%) | $72.25 M(-24.4%) |
| Sep 2021 | - | $95.62 M(+9.5%) |
| Jun 2021 | - | $87.30 M(+3.2%) |
| Mar 2021 | - | $84.61 M(+3.8%) |
| Dec 2020 | $81.55 M | $81.55 M(+5.9%) |
| Sep 2020 | - | $77.00 M(+242.1%) |
| Jun 2020 | - | $22.51 M(-25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $30.07 M(-13.9%) |
| Dec 2019 | $34.94 M(-0.6%) | $34.94 M(+18.5%) |
| Sep 2019 | - | $29.48 M(-7.6%) |
| Jun 2019 | - | $31.91 M(-3.4%) |
| Mar 2019 | - | $33.05 M(-6.0%) |
| Dec 2018 | $35.14 M(+220.3%) | $35.14 M(+1.5%) |
| Sep 2018 | - | $34.63 M(+149.3%) |
| Jun 2018 | - | $13.89 M(+17.6%) |
| Mar 2018 | - | $11.81 M(+7.6%) |
| Dec 2017 | $10.97 M(-19.9%) | $10.97 M(-3.1%) |
| Sep 2017 | - | $11.32 M(-43.5%) |
| Jun 2017 | - | $20.05 M(+50.7%) |
| Mar 2017 | - | $13.30 M(-2.9%) |
| Dec 2016 | $13.71 M(+88.0%) | $13.71 M(+78.2%) |
| Sep 2016 | - | $7.69 M(-14.0%) |
| Jun 2016 | - | $8.94 M(+41.5%) |
| Mar 2016 | - | $6.32 M(-13.3%) |
| Dec 2015 | $7.29 M(-21.0%) | $7.29 M |
| Dec 2014 | $9.23 M | - |
FAQ
- What is Cartesian Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual current liabilities year-on-year change?
- What is Cartesian Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly current liabilities year-on-year change?
What is Cartesian Therapeutics annual total current liabilities?
The current annual current liabilities of RNAC is $68.21 M
What is the all time high annual current liabilities for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual total current liabilities is $81.55 M
What is Cartesian Therapeutics annual current liabilities year-on-year change?
Over the past year, RNAC annual total current liabilities has changed by +$43.13 M (+172.00%)
What is Cartesian Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of RNAC is $21.41 M
What is the all time high quarterly current liabilities for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly total current liabilities is $95.62 M
What is Cartesian Therapeutics quarterly current liabilities year-on-year change?
Over the past year, RNAC quarterly total current liabilities has changed by -$15.25 M (-41.60%)